Julián Panés

1987–2025 年に発表

別表記
Julian Panés
226
論文数
43,572
被引用数
109
h 指数
219
i10 指数

被引用数

Julián Panés の年別被引用数1989 年: 被引用 4 件1990 年: 被引用 7 件1991 年: 被引用 11 件1992 年: 被引用 8 件1993 年: 被引用 6 件1994 年: 被引用 19 件1995 年: 被引用 14 件1996 年: 被引用 14 件1997 年: 被引用 24 件1998 年: 被引用 22 件1999 年: 被引用 59 件2000 年: 被引用 61 件2001 年: 被引用 80 件2002 年: 被引用 77 件2003 年: 被引用 79 件2004 年: 被引用 66 件2005 年: 被引用 66 件2006 年: 被引用 85 件2007 年: 被引用 83 件2008 年: 被引用 103 件2009 年: 被引用 123 件2010 年: 被引用 155 件2011 年: 被引用 253 件2012 年: 被引用 324 件2013 年: 被引用 400 件2014 年: 被引用 383 件2015 年: 被引用 383 件2016 年: 被引用 410 件2017 年: 被引用 445 件2018 年: 被引用 484 件2019 年: 被引用 1,582 件2020 年: 被引用 1,731 件2021 年: 被引用 1,529 件2022 年: 被引用 1,364 件2023 年: 被引用 1,478 件2024 年: 被引用 2,150 件2025 年: 被引用 1,150 件2026 年: 被引用 26 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,380 件、この内訳の 19.5%イギリス: 引用元論文 1,369 件、この内訳の 7.9%中国: 引用元論文 1,249 件、この内訳の 7.2%イタリア: 引用元論文 1,097 件、この内訳の 6.3%カナダ: 引用元論文 1,017 件、この内訳の 5.9%ドイツ: 引用元論文 958 件、この内訳の 5.5%フランス: 引用元論文 857 件、この内訳の 4.9%スペイン: 引用元論文 772 件、この内訳の 4.4%オランダ: 引用元論文 637 件、この内訳の 3.7%ベルギー: 引用元論文 493 件、この内訳の 2.8%日本: 引用元論文 487 件、この内訳の 2.8%オーストラリア: 引用元論文 451 件、この内訳の 2.6%
0%19.5%その他 26.5%

分野

  • Biochemistry, Genetics and Molecular Biology50.2%
  • Medicine35.4%
  • Immunology and Microbiology8.2%
  • Neuroscience2.1%
  • Nursing0.8%
  • Agricultural and Biological Sciences0.7%
  • その他2.6%

トピック

  • Inflammatory Bowel Disease16.2%
  • Microscopic Colitis5.2%
  • Gut microbiota and health2.7%
  • Rheumatoid Arthritis Research and Therapies2.5%
  • Autoimmune and Inflammatory Disorders2.3%
  • Biosimilars and Bioanalytical Methods1.4%
  • その他69.7%

共著者

全論文

検索で開く
  1. Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis

    著者: , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2017 被引用: 1,727

  2. Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials

    著者: , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2022 被引用: 597

  3. Upadacitinib Induction and Maintenance Therapy for Crohn’s Disease

    著者: , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2023 被引用: 427

  4. Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies

    著者: , , , , , , , , , , , , , , , , , , , - The Lancet 2023 被引用: 333

  5. Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marc Ferrante - The Lancet 2022 被引用: 387

  6. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Silvio Danese, Julián Panés, Guillaume Bouguen, Sarah O’Donnell, Benjamin Pariente, Shawn Winer, Stephen B. Hanauer, J -F Colombel - The American Journal of Gastroenterology 2015 被引用: 1,838

  7. Macrophage and neutrophil heterogeneity at single-cell spatial resolution in human inflammatory bowel disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2023 被引用: 286

  8. Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Geert D’Haens - The Lancet 2022 被引用: 316

  9. Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Oleksii Gridnyev, Ihor Hospodarsky, Liudmyla Nykodymivna Prystupa, Mykola Stanislavchuk, Anatoly Pershko, О. Б. Щукина, В. И. Симаненков, Oleksandr Golovchenko, William Holderman, Juan S. Lasa, Jakob Begun, Maria de Lourdes de Abreu Ferrari, Pedro López, A. A. Obrezan, Shiraz Farooq, Felix Tiongco, Abel Novillo, Emiliano Tron, Finlay Macrae, Rupert W. Leong, Lígia Yukie Sassaki, Cyrla Zaltman, Roberto Luiz Kaiser, Andreas Stallmach, Jochen Klaus, Manuel Martı́nez, Azalia Ruiz, Р А Абдулхаков, Vishvinder Sharma, Louis Y Korman, James D. Lord, Bhaktasharan Patel, Timothy E. Ritter - ˜The œLancet. Gastroenterology & hepatology 2023 被引用: 224

  10. IL-12 and IL-23 pathway inhibition in inflammatory bowel disease

    著者: , , , , , , , , , , , , , , , , , , , , , - Nature Reviews Gastroenterology & Hepatology 2023 被引用: 231

  11. Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial

    著者: , , , , , , , , , , , , , , , - The Lancet 2016 被引用: 1,064

  12. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cisca Wijmenga, Robert N. Baldassano, Murray L. Barclay, Theodore M. Bayless, Stephan Brand, Carsten Büning, Albert Cohen, J F. Colombel, Mario Cottone, Laura Stronati, Ted Denson, Martine De Vos, R. D’Incà, Marla C. Dubinsky, Cathryn Edwards, Tim Florin, Denis Franchimont, Richard B. Gearry, Jürgen Glas, A. Van Gossum, Stephen L. Guthery, Jonas Halfvarson, Hein W. Verspaget, Jean‐Pierre Hugot, Amir Karban, Debby Laukens, Ian C. Lawrance, Marc Lémann, Arie Levine, Cécile Libioulle, Édouard Louis, Craig Mowat, William G. Newman, Julián Panés, Anne Phillips, Deborah D. Proctor, Miguel Regueiro, Richard K. Russell, Paul Rutgeerts, Jeremy Sanderson, Miquel Sans, Frank Seibold, A. Hillary Steinhart, Pieter Stokkers, Leif Törkvist, Gerd A. Kullak‐Ublick, David C. Wilson, Thomas D. Walters, Stephan R. Targan, Steven R. Brant, John D. Rioux, Mauro D’Amato, Rinse K. Weersma, Subra Kugathasan, Anne M. Griffiths, John Mansfield, Séverine Vermeire, Richard H. Duerr, Mark S. Silverberg, Jack Satsangi, Stefan Schreiber, Judy H. Cho, Vito Annese, Håkon Håkonarson, Mark J. Daly, Miles Parkes - Nature Genetics 2010 被引用: 2,581

  13. Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn’s Disease

    著者: , , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2020 被引用: 317

  14. Guselkumab for the Treatment of Crohn’s Disease: Induction Results From the Phase 2 GALAXI-1 Study

    著者: , , , , , , , , , , , , , , , , , , , - Gastroenterology 2022 被引用: 198

  15. Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn’s Disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , André D’Hoore, Danny De Looze, Filip Baert, Paul Pattyn, Philippe Zerbib, Frank Zerbib, S Viennot, Jean‐Louis Dupas, P Orsoni, Xavier Hébuterne, Amine Rahili, Matthieu Allez, Yves Panís, Max Reinshagen, Roland Scherer, Andreas Sturm, Wolfgang Kruis, Daniel-Simon Duek, Matti Waterman, Adi Lahat-Zok, Oded Zmora, Hagit Tulchinsky, Yair Edden, Antonino Spinelli, Vito Annese, Imerio Angriman, Gabriele Riegler, Francesco Selvaggi, Bas Oldenburg, Lennard P. L. Gilissen, G Montfort, Mark Löwenberg, Adrianus Willem Bemelman, Raúl Almenara, María Dolores Martín‐Arranz, Mariano García‐Arranz, Javier P. Gisbert, Rosana Palasí, Javier Pérez Gisbert, José Manuel Herrera Justiniano, Ricardo Rada, Ma Teresa Butrón, Ricardo Rada, Antonio López–Sanromán, Joaquín Hinojosa de Val, Amparo Solana, Xavier González-Argenté, C. Martínez Pastor, Héctor Guadalajara, C. Martínez Pastor, Héctor Guadalajara - Gastroenterology 2017 被引用: 485

  16. Assessment of Crohn’s disease-associated small bowel strictures and fibrosis on cross-sectional imaging: a systematic review

    著者: , , , , , , , , , , , , - Gut 2019 被引用: 303

  17. An expert consensus to standardise definitions, diagnosis and treatment targets for anti‐fibrotic stricture therapies in Crohn's disease

    著者: , , , , , , , , , , , , , , , , , , , , - Alimentary Pharmacology & Therapeutics 2018 被引用: 258

  18. Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mercedes Cabello, Qian Cao, Flavio Caprioli, Rute Cerqueira, Baili Chen, Chou‐Chen Chen, Chou-Pin Chen, Cheng‐Tang Chiu, Chang Hwan Choi, Michele Cicala, Olena Datsenko, Pieter Dewint, Eugeni Domènech, Joris Dutré, George Duvall, J. C. Fernández, Rafał Filip, Ronald Fogel, Sharyle Fowler, Toshimitsu Fujii, Masayuki Fukata, Yohei Furumoto, Antonio Gasbarrini, Beata Gawdis-Wojnarska, Cyrielle Gilletta, Paolo Gionchetti, Eran Goldin, Oleksandr Golovchenko, Maciej Gonciarz, Can Gönen, Gaston Gonzalez Segura, Oleksii Gridnyev, T Gyökeres, Xavier Hébuterne, Charlotte Hedin, Per M. Hellström, Ida Hilmi, Ivo Horný, Gyula Horvat, Namiko Hoshi, Luděk Hrdlička, Shunji Ishihara, Olha Ivanishyn, Byung Ik Jang, Odery Junior, Takashi Kagaya, Shuji Kanmura, Marina Karakina, Nakai Katsuhiko, Jarosław Kierkuś, Hyo Jong Kim, Tae-Oh Kim, Young‐Ho Kim, G Kiss, Jochen Klaus, D Kleczkowski, Maria Kłopocka, Taku Kobayashi, Iwona Kobielusz‐Gembala, Ja Seol Koo, Adam Kopoń, Tetiana Kravchenko, Masatoshi Kudo, Kwang An Kwon, Paula Lago, David Laharie, Ian C. Lawrance, Jarosław Leszczyszyn, Yan Li, Milan Lukáš ほか 64 名 - Gastroenterology 2023 被引用: 92

  19. Sphingosine 1-phosphate modulation and immune cell trafficking in inflammatory bowel disease

    著者: , , , , , , , , , , , , , , , , , - Nature Reviews Gastroenterology & Hepatology 2022 被引用: 131

  20. Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future Directions

    著者: , , , , , , , , - Clinical Gastroenterology and Hepatology 2015 被引用: 446

  21. Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study

    著者: , , , , , , , , , , , , , , , , , , , , , - The Lancet 2017 被引用: 446

  22. Efficacy of Upadacitinib in a Randomized Trial of Patients With Active Ulcerative Colitis

    著者: , , , , , , , , , , , - Gastroenterology 2020 被引用: 277

  23. Development and Validation of a Simplified Magnetic Resonance Index of Activity for Crohn’s Disease

    著者: , , , , , , , , , , , , - Gastroenterology 2019 被引用: 216

  24. Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn’s disease

    著者: , , , , , , , , , , - Alimentary Pharmacology & Therapeutics 2011 被引用: 653